Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07619547 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Longitudinal Immunophenotyping of Patients With Inflammatory Bowel Disease

StatusRecruiting
PhaseNot specified
Started
View on ClinicalTrials.gov ↗

Record History

The 50 most recent of 82 record versions are listed below. See every version on ClinicalTrials.gov ↗

  1. Start date: Oct 13, 2026 to Oct 14, 2026
  2. Start date: Oct 12, 2026 to Oct 13, 2026
  3. Start date: Oct 11, 2026 to Oct 12, 2026
  4. Start date: Oct 8, 2026 to Oct 11, 2026
  5. Start date: Oct 7, 2026 to Oct 8, 2026
Show 4 earlier versionsHide 4 earlier versions
  1. Start date: Oct 6, 2026 to Oct 7, 2026
  2. Start date: Oct 5, 2026 to Oct 6, 2026
  3. Start date: Oct 4, 2026 to Oct 5, 2026
  4. Trial status: Not Yet Recruiting to Recruiting Start date: Sep 20, 2026 to Oct 4, 2026 · Eligibility criteria expanded, about 11 words Show 2 more changesShow less
    • Start date: Sep 20, 2026 to Oct 4, 2026
    • Eligibility criteria expanded, about 11 words
  1. Recruitment opened Start date: Sep 17, 2026 to Sep 20, 2026v73 Show 1 more changeShow less
    • Start date: Sep 17, 2026 to Sep 20, 2026
  2. Start date: Sep 16, 2026 to Sep 17, 2026v72
  3. Start date: Sep 15, 2026 to Sep 16, 2026v71
  4. Start date: Sep 14, 2026 to Sep 15, 2026v70
  5. Start date: Sep 10, 2026 to Sep 14, 2026v69
  6. Start date: Sep 9, 2026 to Sep 10, 2026v68
  7. Start date: Sep 8, 2026 to Sep 9, 2026v67
  8. Start date: Sep 7, 2026 to Sep 8, 2026v66
  9. Start date: Sep 6, 2026 to Sep 7, 2026v65
  10. Start date: Sep 3, 2026 to Sep 6, 2026v64
  11. Start date: Sep 2, 2026 to Sep 3, 2026v63
  12. Start date: Sep 1, 2026 to Sep 2, 2026v62
  13. Start date: Aug 31, 2026 to Sep 1, 2026v61
  14. Start date: Aug 30, 2026 to Aug 31, 2026v60
  15. Start date: Aug 27, 2026 to Aug 30, 2026v59
  16. Start date: Aug 26, 2026 to Aug 27, 2026v58
  17. Start date: Aug 25, 2026 to Aug 26, 2026v57
  18. Start date: Aug 24, 2026 to Aug 25, 2026v56
  19. Start date: Aug 23, 2026 to Aug 24, 2026v55
  20. Start date: Aug 20, 2026 to Aug 23, 2026v54
  21. Start date: Aug 19, 2026 to Aug 20, 2026v53
  22. Start date: Aug 18, 2026 to Aug 19, 2026v52
  23. Start date: Aug 17, 2026 to Aug 18, 2026v51
  24. Start date: Aug 16, 2026 to Aug 17, 2026v50
  25. Start date: Aug 13, 2026 to Aug 16, 2026v49
  26. Start date: Aug 12, 2026 to Aug 13, 2026v48
  27. Start date: Aug 11, 2026 to Aug 12, 2026v47
  28. Start date: Aug 10, 2026 to Aug 11, 2026v46
  29. Start date: Aug 7, 2026 to Aug 10, 2026v45
  30. Start date: Aug 6, 2026 to Aug 7, 2026v44
  31. Start date: Aug 5, 2026 to Aug 6, 2026v43
  32. Start date: Aug 4, 2026 to Aug 5, 2026v42
  33. Start date: Aug 3, 2026 to Aug 4, 2026v41
  34. Start date: Aug 2, 2026 to Aug 3, 2026v40
  35. Start date: Jul 30, 2026 to Aug 2, 2026v39
  36. Start date: Jul 29, 2026 to Jul 30, 2026v38
  37. Start date: Jul 28, 2026 to Jul 29, 2026v37
  38. Start date: Jul 27, 2026 to Jul 28, 2026v36
  39. Start date: Jul 26, 2026 to Jul 27, 2026v35
  40. Start date: Jul 23, 2026 to Jul 26, 2026v34
  41. Start date: Jul 22, 2026 to Jul 23, 2026v33
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Background: Inflammatory bowel disease (IBD) is a term used to describe disorders that cause long-term inflammation in the digestive tract. Symptoms include stomach pain, diarrhea, and bleeding. Crohn's disease and ulcerative colitis are the 2 main types of IBD. Researchers want to conduct a natural history study to learn more about whether genetic factors can cause IBD; how immune cells contribute to IBD; and how diet, drugs, and disease affect those cells. Objective: To better understand IBD over time. Eligibility: Adults aged 18 to 85 years with Crohn's disease, ulcerative colitis, or another IBD. Their healthy relatives are also needed. Design: Affected participants will have clinic visits every 6 months for 3 years. Once a year, they will have these procedures: A physical exam with blood and stool samples. Ultrasound of the abdomen. A wand will be rolled over the skin. It uses sound waves to capture images of the intestines. Magnetic resonance imaging (MRI) scan. They will lie on a table that slides into a tube. Magnetic fields will capture images of the intestines. Colonoscopy. A long, flexible tube with a video camera will be inserted into the rectum to view the entire colon. Up to 12 tissue samples may be taken. Upper endoscopy, for those with Crohn's disease. A long, thin tube with a camera will be inserted through the mouth and into the first part of the small intestine. Up to 12 small tissue samples may be taken. Questionnaires. Participants will answer questions about their disease and their diet. Midyear visits will include a physical exam, blood and stool collection, ultrasound, and questionnaires Healthy relatives will have 1 blood draw for genetic tests.
Trial Details
NCT Number NCT07619547
Lead Sponsor National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Conditions Inflammatory Bowel Disease, Crohn's Disease, Ulcerative Colitis
Enrollment 100 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov